NCT03521830 Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma Status RECRUITING Phase PHASE2
NCT03517488 A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT03467789 Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma Status COMPLETED Phase PHASE1
NCT03370861 How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes Status TERMINATED Phase N/A
NCT03331874 RCM to Diagnose BCC - Reflectance Confocal Microscopy to Diagnose Basal Cell Carcinoma Status COMPLETED Phase N/A
NCT03070691 Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS) Status WITHDRAWN Phase PHASE2/PHASE3
NCT03035188 Neoadjuvant Vismodegib in Patients With Large and/or Recurrent Resectable Basal Cell Carcinoma Status COMPLETED Phase PHASE2
NCT02902822 Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo Status COMPLETED Phase NA
NCT02834013 Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02825511 Assessment of the Clinic-pathological Correlation of Basal Cell Carcinoma Status COMPLETED Phase N/A
NCT02781389 Vismodegib on Locally Advanced Basal Cell Carcinoma Under Real World Conditions Status COMPLETED Phase N/A
NCT02667574 Study Evaluating the Interest of Vismodegib as Neo-adjuvant Treatment of Basal Cell Carcinoma (BCC) Status COMPLETED Phase PHASE2
NCT02662244 Long-pulsed 1064 nm Nd:YAG Laser Treatment of Basal Cell Carcinoma Status COMPLETED Phase NA
NCT02639117 Photodynamic Therapy and Vismodegib for Multiple Basal Cell Carcinomas Status COMPLETED Phase PHASE1